Bio

Research scientist with 20 years experience in biologics drug development from target identification through IND approval and post-marketing risk mitigation. Experienced program and group leader focusing on antibody based therapeutics, clinical assay development, translational medicine/biomarker discovery and business development due diligence. Experienced in KOL outreach, research grant administration, and scientific collaborations with a focus on oncology, neurology, infectious disease and autoimmunity.